Quotient Limited – NASDAQ:QTNT

Financial Health
0
1
2
3
4
5
6
7
8
9

Quotient Limited stock price monthly change

-100.00%
month

Quotient Limited stock price quarterly change

-100.00%
quarter

Quotient Limited stock price yearly change

-100.00%
year

Quotient Limited key metrics

Market Cap
N/A
Enterprise value
262.07M
P/E
-0.01
EV/Sales
7.00
EV/EBITDA
-3.14
Price/Sales
0.04
Price/Book
N/A
PEG ratio
N/A
EPS
-48.02
Revenue
38.51M
EBITDA
-83.55M
Income
-122.23M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
-331.54%
Oper. margin
-309.92%
Gross margin
0.75%
EBIT margin
-309.92%
EBITDA margin
-216.95%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Quotient Limited stock price history

Quotient Limited stock forecast

Quotient Limited financial statements

Quotient Limited (NASDAQ:QTNT): Profit margin
Jun 2021 9.08M -24.39M -268.43%
Sep 2021 9.46M -27.10M -286.31%
Dec 2021 10.17M -44.82M -440.63%
Mar 2022 9.78M -25.91M -264.79%
Quotient Limited (NASDAQ:QTNT): Earnings per share (EPS)
2022-06-24 -13.6 -10
2022-08-09 -8 -14.8
2022-11-14 -9.43 -10.81
0%
Yield TTM
Quotient Limited (NASDAQ:QTNT): Payout ratio
Payout ratio 0%
Quotient Limited (NASDAQ:QTNT): Dividend Yield
2018 21.83%
2019 8.41%
2020 14.85%
2021
2022 34.34%
Quotient Limited (NASDAQ:QTNT): Debt to assets
Mar 2022 193989000 338.08M 174.28%
Jun 2022 174590000 325.66M 186.53%
Sep 2022 127905000 309.99M 242.36%
Dec 2022 119326000 328.21M 275.05%
Quotient Limited (NASDAQ:QTNT): Cash Flow
Jun 2021 -32.05M 12.64M 88.11M
Sep 2021 -26.64M 30.37M -129K
Dec 2021 -69.53M 14.27M 87.92M
Mar 2022 -22.87M -569K -180K

Quotient Limited alternative data

Quotient Limited (NASDAQ:QTNT): Employee count
Aug 2023 450
Sep 2023 450
Oct 2023 450
Nov 2023 450
Dec 2023 450
Jan 2024 450
Feb 2024 450
Mar 2024 450
Apr 2024 450
May 2024 450
Jun 2024 450
Jul 2024 450

Quotient Limited other data

Quotient Limited (NASDAQ:QTNT): Insider trades (number of shares)
Period Buy Sel
Dec 2021 50000 0
Jan 2022 0 3847
Feb 2022 60000 0
May 2022 0 4203
Jun 2022 218140 0
Jul 2022 0 4863
Sep 2022 1000000 0
Oct 2022 0 8255607
Nov 2022 0 26014
Transaction Date Insider Security Shares Price per share Total value Source
Sale
BUCKLE ISABELLE director
Ordinary Shares 1,014 $0.88 $892
Option
KIBORO ALI officer: Chief Financial Officer
Restricted Stock Units 1,526 N/A N/A
Option
KIBORO ALI officer: Chief Financial Officer
Ordinary Shares 1,526 N/A N/A
Sale
VON PRONDZYNSKI HEINO director
Ordinary Shares 25,000 $1.18 $29,500
Option
LARUE CATHERINE director
Ordinary Shares 6,917 N/A N/A
Option
AEBISCHER THOMAS director
Ordinary Shares 6,917 N/A N/A
Option
HALLSWORTH FREDERICK director
Restricted Stock Units 6,917 N/A N/A
Option
HALLSWORTH FREDERICK director
Ordinary Shares 6,917 N/A N/A
Sale
PERCEPTIVE ADVISORS LLC 10 percent owner
Ordinary Shares, nil par value 8,255,607 $0.08 $660,449
Option
MCDONOUGH BRIAN director
Ordinary Shares 6,917 N/A N/A
Monday, 20 May 2024
https://www.defenseworld.net
https://www.defenseworld.net
Friday, 30 December 2022
PennyStocks
Wednesday, 28 December 2022
PennyStocks
Wednesday, 9 November 2022
The Motley Fool
Tuesday, 9 August 2022
Seeking Alpha
Zacks Investment Research
Thursday, 7 July 2022
PennyStocks
Friday, 24 June 2022
Seeking Alpha
Zacks Investment Research
Wednesday, 22 June 2022
Benzinga
Friday, 17 June 2022
GlobeNewsWire
Tuesday, 8 February 2022
Seeking Alpha
Zacks Investment Research
Proactive Investors
Monday, 31 January 2022
GlobeNewsWire
Zacks Investment Research
Friday, 31 December 2021
Zacks Investment Research
Friday, 17 December 2021
Zacks Investment Research
Monday, 22 November 2021
Zacks Investment Research
Monday, 15 November 2021
Zacks Investment Research
Tuesday, 9 November 2021
Seeking Alpha
Thursday, 14 October 2021
GlobeNewsWire
Tuesday, 12 October 2021
GlobeNewsWire
Tuesday, 5 October 2021
GlobeNewsWire
Monday, 4 October 2021
Zacks Investment Research
Saturday, 2 October 2021
Pulse2
Friday, 1 October 2021
The Motley Fool
GlobeNewsWire
Wednesday, 1 September 2021
GlobeNewsWire
  • When is Quotient Limited's next earnings date?

    Unfortunately, Quotient Limited's (QTNT) next earnings date is currently unknown.

  • Does Quotient Limited pay dividends?

    No, Quotient Limited does not pay dividends.

  • What is Quotient Limited's stock symbol?

    Quotient Limited is traded on the NASDAQ under the ticker symbol "QTNT".

  • What is Quotient Limited's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of Quotient Limited?

    Shares of Quotient Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Quotient Limited's key executives?

    Quotient Limited's management team includes the following people:

    • Mr. Peter Buhler Executive Officer(age: 55, pay: $761,150)
  • How many employees does Quotient Limited have?

    As Jul 2024, Quotient Limited employs 450 workers.

  • When Quotient Limited went public?

    Quotient Limited is publicly traded company for more then 11 years since IPO on 16 Apr 2014.

  • What is Quotient Limited's official website?

    The official website for Quotient Limited is quotientbd.com.

  • How can i contact Quotient Limited?

    Quotient Limited can be reached via phone at +41 22 716 98 00.

Quotient Limited company profile:

Quotient Limited

quotientbd.com
Exchange:

NASDAQ

Full time employees:

450

Industry:

Medical - Devices

Sector:

Healthcare

Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological disease screening, and molecular disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, which enable the identification of blood group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. The company also offers MosaiQ SDS Microarray that is designed as a serological disease screening microarray comprised assays to detect cytomegalovirus and Syphilis; MosaiQ MDS Microarray that is designed as a molecular disease screening microarray test for donor red cells or source plasma; MosaiQ IH Microarray as a blood grouping microarray; MosaiQ Autoimmune Microarray; MosaiQ COVID-19; and MosaiQ IH3 Microarray. It sells its products to hospitals, donor collection agencies, independent testing laboratories, original equipment manufacturers, and blood banking operation and other diagnostics companies. Quotient Limited was founded in 2007 and is headquartered in Eysins, Switzerland.

Jtc House, 28 Esplanade
, VAUD 1262

CIK: 0001596946
ISIN: JE00BLG2ZQ72
CUSIP: G73268107